Does improving maternal knowledge of vaccines impact infant immunization rates? A community-based randomized-controlled trial in Karachi, Pakistan

Owais, Aatekah; Hanif, Beenish; Siddiqui, Amna R.; Agha, Ajmal; Zaidi, Anita K. M.
January 2011
BMC Public Health;2011, Vol. 11 Issue 1, p239
Academic Journal
Background: In Pakistan, only 59-73% of children 12-23 months of age are fully immunized. This randomized, controlled trial was conducted to assess the impact of a low-literacy immunization promotion educational intervention for mothers living in low-income communities of Karachi on infant immunization completion rates. Methods: Three hundred and sixty-six mother-infant pairs, with infants aged = 6 weeks, were enrolled and randomized into either the intervention or control arm between August - November 2008. The intervention, administered by trained community health workers, consisted of three targeted pictorial messages regarding vaccines. The control group received general health promotion messages based on Pakistan's Lady Health Worker program curriculum. Assessment of DPT/Hepatitis B vaccine completion (3 doses) was conducted 4-months after enrollment. A Poisson regression model was used to estimate effect of the intervention. The multivariable Poisson regression model included maternal education, paternal occupation, ownership of home, cooking fuel used at home, place of residence, the child's immunization status at enrollment, and mother's perception about the impact of immunization on child's health. Results: Baseline characteristics among the two groups were similar. At 4 month assessment, among 179 motherinfant pairs in the intervention group, 129 (72.1%) had received all 3 doses of DPT/Hepatitis B vaccine, whereas in the control group 92/178 (51.7%) had received all 3 doses. Multivariable analysis revealed a significant improvement of 39% (adjusted RR = 1.39; 95% CI: 1.06-1.81) in DPT-3/Hepatitis B completion rates in the intervention group. Conclusion: A simple educational intervention designed for low-literate populations, improved DPT-3/Hepatitis B vaccine completion rates by 39%. These findings have important implications for improving routine immunization rates in Pakistan.


Related Articles

  • Hepatitis B vaccines.  // Weekly Epidemiological Record;10/2/2009, Vol. 84 Issue 40, p405 

    The article discusses the use of vaccines against hepatitis B (HB). It notes that as of 2008, there are 177 countries which employ HB vaccines in their national infant immunization programmes. It cites studies which show the effectiveness of the vaccine in reducing the risk of infants and...

  • Timing of Zero Dose of OPV, First Dose of Hepatitis B and BCG Vaccines. KURUVILLA, THOMAS A.; BRIDGITTE, AKILA // Indian Pediatrics;Nov2009, Vol. 46 Issue 11, p1013 

    The Indian Academy of Pediatrics has been recommending Hepatitis B vaccination for infants since 1992. This community based cross sectional study carried out in the rural and urban areas of Tamil Nadu found no significant rural urban difference in the proportions of children who had received BCG...

  • Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules. Agladioglu, S.; Beyazova, U.; Camurdan, A.; Sahin, F.; Atak, A. // Infection;Aug2010, Vol. 38 Issue 4, p269 

    Neonatal immunization with hepatitis B (HB) vaccine induces protective levels of antibody (anti-HBs ≥10 IU/L) in a majority of vaccines. However, the duration of protection after HB vaccination in infants is unknown. A smaller proportion of children vaccinated beginning at birth with three...

  • Evaluation of the Impact of Hepatitis B Vaccination in Adults in Jiangsu Province, China. Zhu, Liguo; Zhai, Xiangjun; Zhu, Yefei; Xu, Weiguo; Bao, Changjun; Peng, Hong; Bian, Qian; Yang, Haitao; Wang, Hua; Hu, Zhibin; Shen, Hongbing // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Hepatitis B immunization programs for newborns, children, and adolescents in China have shown remarkable results. To establish whether there would be any benefit in extending the program to cover older individuals, we examined both the epidemiology of hepatitis B virus (HBV) infection and the...

  • Worldwide implementation of hepatitis B vaccination of newborns, 2006.  // Weekly Epidemiological Record;11/28/2008, Vol. 83 Issue 48, p429 

    The article reports on the findings of the survey from the 2006 World Health Organization (WHO) and United Nations International Children's Emergency Fund (UNICEF) concerning the implementation of hepatitis B vaccination of newborns. WHO and UNICEF have published coverage estimates for routine...

  • Revaccination of non-responding infants delivered by HBsAg-positive mothers. Hasanjani Roushan, M. R.; Pasha, Y. Zahed; Saghebi, R.; Kohi, F. // European Journal of Clinical Microbiology & Infectious Diseases;Jun2005, Vol. 24 Issue 6, p434 

    Evaluates the efficacy of revacinnation with two additional doses of hepatitis B virus (HBV) vaccine in non-responding infants delivered by hepatitis B surface antigen (HBsAg)-positive mothers in Yahyanejad Hospital in Babol, Iran. Performance of post-vaccination tests to detect HBsAg and...

  • Seroepidemiology of Hepatitis B in Greek Children 6 Years After the Implementation of Universal Vaccination. Papaevangelou, V.; Hadjichristodoulou, C.; Cassimos, D.; Pantelaki, K.; Tzivaras, A.; Hatzimichael, A.; Theodoridou, M. // Infection;Apr2008, Vol. 36 Issue 2, p135 

    The seroepidemiology of hepatitis B in children living in Greece 6 years post-implementation of universal infant immunization (1998) was studied. We collected 90–100 sera/year of age, stratified by geographic region. The prevalence of HbsAg(+) was 0.6% (95% CI 0.3–1.3) whereas 4.5%...

  • Immune response in infants after universal hepatitis B vaccination: a community-based study in Malaysia. Hon Kit Cheang; Hui Tong Wong; Shu Chien Ho; Kee Siang Chew; Way Seah Lee // Singapore Medical Journal;2013 Apr, Vol. 54 Issue 4, p224 

    Introduction This study aimed to assess the immune response in infants who received the three-shot hepatitis B vaccine in Malaysia. Methods Consecutive infants born between March 2002 and April 2010 who received three doses of hepatitis B vaccine at a community clinic in Malaysia were enrolled...

  • Thrombocytopenic purpura: adverse reaction to a combined immunisation (recombinant hepatitis B and measles-mumps-rubella-vaccine) and after therapy with Co-Trimoxazole. Kertzscher, F.; Kiefel, V.; Lenk, H.; Müller, A. // European Journal of Pediatrics. Supplement;1999, Vol. 158, pS209 

    Two cases of thrombocytopenic purpura are reported: one after co-trimoxazole therapy (case A) and anotherfollowing combined immunisation (recombinant hepatitis B/measles-mumps-rubella (MMR)) (case B). In both cases the course of thrombocytopenic purpura was of short duration. The platelet count...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics